Cell & Gene Therapy Innovation · the Circle
What delivers. What sustains.
Who reaches the patient.
Hotel Palace Berlin · 10–11 February 2027
the Why
01
Cell and gene therapy has crossed from experimental to clinical. Multiple modalities are approved. The constraint now is not the biology — it is the system that delivers the biology to the patient.
02
Manufacturing scalability, supply chain resilience, reimbursement architecture and regulatory coherence remain unsolved at the scale the field demands. The delay costs lives.
03
Platform choices, CMC commitments, vector supply partnerships and market access strategy are being set by a small number of principals. Those decisions will define patient outcomes for a decade.
04
CGTI is closed. Invite-only. No audience, no broadcast, no performative Q&A. The conversation is structured around decisions, not presentations. The room is the mechanism.
The gap is not scientific.
It is systemic.
Approved therapies sit in manufacturing pipelines that cannot scale. Vector supply constraints delay trials. Reimbursement models do not reflect the value of curative interventions. These are decision problems, not science problems. CGTI is the room where those decisions are tested — by the principals who must make them.
The conversation at CGTI is structured around the decisions the field cannot defer. Not what could be done. What will be decided.
in the room.
the Room
The principals who shape cell and gene therapy at the level of science, operations and clinical delivery.
CGTI convenes CDOs, CMOs, heads of manufacturing, clinical operations leads and regulatory strategy principals. Not from every organisation — from the ones where the decisions are actually made.
The room
Closed. Invite-only. The chair is a practitioner, not a moderator. The structure is built for alignment, not performance.
View facultyFaculty
Faculty name
on confirmation
Role · Department
Organisation
Faculty name
on confirmation
Role · Department
Organisation
Faculty name
on confirmation
Role · Department
Organisation
Faculty grid populated on receipt of confirmed CSV (published records, deduplicated, rows of 3). Chair is never a card.
in the room.
Where it convenes.
Berlin · Singapore · London
The room
Confirmed organisations across cell therapy, gene therapy, vector manufacturing, CDMOs, regulatory and reimbursement. The wall reflects the room.
Organisation
Organisation
Organisation
Organisation
Organisation
Organisation
Company wall populated on receipt of confirmed delegate list. Rows of 6, white 1:1 tiles, institutional register.